论文信息 - Combination Treatment With Letermovir and Ganciclovir for Maintenance Therapy of Multidrug-resistant CMV Infection in a Liver Transplant Recipient.

Combination Treatment With Letermovir and Ganciclovir for Maintenance Therapy of Multidrug-resistant CMV Infection in a Liver Transplant Recipient.

We report the case of a liver transplant recipient, cytomegalovirus (CMV) donor-positive (D+), recipient-negative (R−), with primary multidrug-resistant CMV infection treated with a combination therapy of letermovir and (val)ganciclovir.

T. Berney | C. van Delden | L. Elkrief | D. Neofytos | I. Kronig

[1] N. Kneidinger,et al. Letermovir for difficult to treat cytomegalovirus infection in lung transplant recipients , 2020, Pneumologie.

[2] Deepali Kumar,et al. Letermovir as Salvage Therapy for Cytomegalovirus Infection in Transplant Recipients. , 2020 .

[3] S. Nathan,et al. Single‐center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipients , 2019, Transplant infectious disease : an official journal of the Transplantation Society.

[4] D. Michel,et al. Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient , 2019, BMC Infectious Diseases.

[5] P. Frange,et al. Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases , 2019, Antimicrobial Agents and Chemotherapy.

[6] S. Chou,et al. Emergence of letermovir resistance in a lung transplant recipient with ganciclovir‐resistant cytomegalovirus infection , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7] Michael Boeckh,et al. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic‐Cell Transplantation , 2017, The New England journal of medicine.

[8] M. Boeckh,et al. How we treat cytomegalovirus in hematopoietic cell transplant recipients. , 2009, Blood.